

CHO-K1/Mouse CB2 Stable Cell
Item | Cat# | Price |
Stable Cell Line | SNB-G-0049B | $19,800 |
Compound Testing Services | CT-001 | $1,850 per 384w plate (Up To 16 cpds Dose) |
Product Description
The cannabinoid receptor 2 (CB2) is a G protein-coupled receptor within the endocannabinoid system, primarily distributed in the peripheral immune system (e.g., spleen, tonsils, and immune cells like B cells, T cells, and macrophages), and also expressed in microglia of the central nervous system. Its core function is to modulate immune responses and inflammation; activation suppresses pro-inflammatory cytokine release, exerting anti-inflammatory and immunomodulatory effects. Thus, CB2 is a non-psychoactive potential target for treating inflammatory diseases, neuropathic pain, and autoimmune disorders.
Screeningbio’s CHO-K1/Mouse CB2 cell line overexpress CNR2 and is designed to detect decreases in intracellular cAMP levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit can be used to detect the signal.
Product Specifications
Target Type | GPCR |
Species | Mouse |
HGNC Symbol | CNR2 |
Accession Number | NM_009924 |
Parental Line | CHO-K1 |
Lot# | See Vial |
Storage | Liquid Nitrogen |
Data
![CHO-K1/Mouse CB2 Agonist Assay. CHO-K1/Mouse CB2 cells were stimulated with 2.5 μM Forskolin and treated with reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.](https://static.wixstatic.com/media/cbf7de_3c2af3163288476dbb9f02cc335ec70e~mv2.png/v1/fill/w_75,h_75,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/cbf7de_3c2af3163288476dbb9f02cc335ec70e~mv2.png)
Target Background
The cannabinoid receptor 2 (CB2) is a G protein-coupled receptor within the endocannabinoid system, primarily distributed in the peripheral immune system (e.g., spleen, tonsils, and immune cells like B cells, T cells, and macrophages), and also expressed in microglia of the central nervous system.
Its core function is to modulate immune responses and inflammation; activation suppresses pro-inflammatory cytokine release, exerting anti-inflammatory and immunomodulatory effects. Thus, CB2 is a non-psychoactive potential target for treating inflammatory diseases, neuropathic pain, and autoimmune disorders.